glp-1 receptor agonist after bariatric surgery weight regain More patients are now adding medications surgery, especially for regain, plateaus, or added metabolic support. But this isn't a simple “add-on fix.” It comes with real changes in Association between plausible genetic factors
Description
A few GLP-1 agonists currently in phase 3 trials are higher-dose injectable semaglutide 7.2 mg (Novo Nordisk), oral semaglutide 50 mg (Novo Nordisk) and orforglipron (Eli Lilly)

Preclinical Research: Animal studies have demonstrated that GLP-1 agonists can reduce drug-seeking behavior in rodent models of cocaine and opioid addiction

DAP, DJE, JBK and VMJ are stockholders of Pfizer Inc

In some case reports, exenatide administration has been associated with the development of panniculitis, although a causal association has not been proven [112-114]

doi: 10.1172/JCI42845
